MXCT vs MEDP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

MXCT

35.8
AI Score
VS
MEDP Wins

MEDP

37.7
AI Score

Investment Advisor Scores

MXCT

36score
Recommendation
SELL

MEDP

38score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MXCT MEDP Winner
Revenue 16.92M 1.41B MEDP
Net Income -13.62M 245.23M MEDP
Net Margin -80.5% 17.3% MEDP
Operating Income -16.42M 288.33M MEDP
ROE -8.6% 56.5% MEDP
ROA -7.4% 11.9% MEDP
Total Assets 184.67M 2.06B MEDP
Cash 15.04M 502.69M MEDP
Current Ratio 12.26 0.73 MXCT
Free Cash Flow -12.96M 283.07M MEDP

Relative Price Performance (Last 90 Days)

MXCT 1M: -15.7% · 3M: -15.7% MEDP 1M: +1.1% · 3M: +6.1%

Current Technical Phase

MXCT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.7%), weak momentum, RSI 33

RSI (14): 33.3 · Price: $1.07

MEDP

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.2 · Price: $599.47

Fundamentals Snapshot

Metric MXCT MEDP
Market Cap — —
Forward P/E -4.4 31.0
Trailing P/E — 35.1
Revenue (TTM) — —
Revenue Growth -0.1% 0.2%
Gross Margin 0.8% 0.7%
Operating Margin -1.4% 0.2%
EPS -0.33 17.04
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MEDP is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.